3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
17
Precursor Cell Lymphoblastic Leukemia-Lymphoma
15
Myelodysplastic Syndromes
15
Hematologic Neoplasms
8
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
7
Lymphoma, Non-Hodgkin
6
Neuroblastoma
5
Leukemia, Biphenotypic, Acute
5
Myeloproliferative Disorders
4
Graft vs Host Disease
4
Multiple Myeloma
3
Medulloblastoma
3
Lymphoma, Large B-Cell, Diffuse
3
Leukemia
3
Hodgkin Disease
3
Ganglioneuroblastoma
3
Blastic Plasmacytoid Dendritic Cell Neoplasm
3
Lymphoma
2
Leukemia, Myelomonocytic, Juvenile
2
Leukemia, Myelomonocytic, Chronic
2
Anemia, Refractory, with Excess of Blasts
2
Teratoma
1
Sarcoma, Myeloid
1
Rhabdomyosarcoma
1
Rhabdoid Tumor
1
Retinoblastoma
1
Recurrence
1
Pyloric Stenosis, Hypertrophic
1
Pinealoma
1
Neurofibrosarcoma
1
Interventions
pirtobrutinib
6
Cyclophosphamide
6
Mycophenolic Acid
5
fludarabine phosphate
4
fludarabine
4
Rituximab
4
Melphalan
4
Azacitidine
4
venetoclax
3
ibrutinib
3
Whole-Body Irradiation
3
Tacrolimus
3
Mesna
3
Peripheral Blood Stem Cell Transplantation
2
Patient Reported Outcome Measures
2
Lenalidomide
2
Cyclosporine
2
Busulfan
2
Brentuximab Vedotin
2
Bone Marrow Transplantation
2
Blood Specimen Collection
2
Bendamustine Hydrochloride
2
zanubrutinib
1
ruxolitinib
1
ponatinib
1
pembrolizumab
1
nilotinib
1
idelalisib
1
idecabtagene vicleucel
1
cedazuridine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Hematologic Diseases
×
Thiotepa
×
1 year
×
Clear all
No trials found.